NextCell Pharma AB reported earnings results for the second quarter and six months ended February 29, 2024. For the second quarter, the company reported sales was SEK 2.33 million compared to SEK 2.11 million a year ago. Revenue was SEK 2.4 million compared to SEK 2.73 million a year ago. Net loss was SEK 10.09 million compared to SEK 11.41 million a year ago. Basic loss per share from continuing operations was SEK 0.29 compared to SEK 0.33 a year ago.
For the six months, sales was SEK 6.58 million compared to SEK 4.24 million a year ago. Revenue was SEK 7.1 million compared to SEK 5.75 million a year ago. Net loss was SEK 19.89 million compared to SEK 20.33 million a year ago. Basic loss per share from continuing operations was SEK 0.58 compared to SEK 0.59 a year ago.